superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2021-09-30
- Valid until
- 2022-03-31
- Published
- 2021-10-27
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 1,610,100,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Eli Lilly and Company quarterly research and development: 1,708,900,000 United States dollar", as of 2021-09-30 (until 2022-03-31). Claim clm_0D1C949297F8, https://asof.is/claim/clm_0D1C949297F8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm.
APA
AsOf. (2021). Eli Lilly and Company quarterly research and development: 1,708,900,000 United States dollar (as of 2021-09-30 (until 2022-03-31)) [Record clm_0D1C949297F8]. Retrieved November 8, 2026, from https://asof.is/claim/clm_0D1C949297F8 (source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm)
BibTeX
@misc{asof_clm_0D1C949297F8,
author = {AsOf},
title = {Eli Lilly and Company quarterly research and development: 1,708,900,000 United States dollar},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_0D1C949297F8}},
note = {Claim clm\_0D1C949297F8, as of 2021-09-30 (until 2022-03-31); source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_0D1C949297F8.md/v1/claims/clm_0D1C949297F8submit a correction